Aliccia Bollig-Fischer, PhD
Assistant Professor Department of Oncology
4100 John R.
Detroit, MI 48201
- Functional Genomics
- Systems & Computational Biology
- Molecular Biomarkers & Targeted Therapeutics
Research in Dr. Bollig-Fischer's laboratory advances cutting-edge genomic methodologies, molecular biology approaches, and innovative bioinformatics. The goal is to tackle clinically relevant cancer research challenges with a strong focus on disparities in outcomes for subsets of patients and related mechanistic understanding of how mutation-activated oncogenes are influenced by other biological factors in their role to drive cancer. In a nutshell, Dr. Bollig-Fischer's research goal is realize the full potential of precision medicine.
Bao B, Mitrea C, Wijesinghe P, Marchetti L, Girsch E, Farr RL, Boerner JL, Mohammad R, Dyson G, Terlecky SR, Bollig-Fischer A. Treating triple negative breast cancer cells with erlotinib plus a select antioxidant overcomes drug resistance by targeting cancer cell heterogeneity. Sci Rep. 2017 Mar 10;7:44125.
Bollig-Fischer A. How the future of clinical cancer diagnostics can contribute to overcoming race-associated cancer disparities. Expert Rev Mol Diagn. 2016;16:1233-35.
Wijesinghe P, Bollig-Fischer A. Lung Cancer Genomics in the Era of Accelerated Targeted Drug Development. Adv Exp Med Biol. 2016;890:1-23.
Education and Training:
PhD (2003) Michigan State University, East Lansing, MI
Cancer Biology Courses Taught:
CB7240 Principles of Cancer Therapy
CB7300 Functional Genomics and Bioinformatics
CB7990 Research Technologies in Cancer Research